The company is into manufacturing of agrochemicals and in 2015 it forayed into pharmaceuticals.
The company acquired Medicamen Biotech Limited in 2015 which is engaged in manufacturing pharmaceutical formulations.
Financial Results:
Shivalik Rasayan Ltd reported Revenues for Q1FY24 of ₹64.47 Crores up from ₹57.83 Crore year on year, a rise of 11.48%.
Total Expenses for Q1FY24 of ₹57.38 Crores up from ₹50.03 Crores year on year, a rise of 14.69%.
Consolidated Net Profit of ₹6.48 Crores down 23.4% from ₹8.46 Crores in the same quarter of the previous year.
The Earnings per Share is ₹2.80, down 36.36% from ₹4.40 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.